Correction: Mapping and role of T cell response in SARS-CoV-2-infected mice.
作者信息
Zhuang Zhen, Lai Xiaomin, Sun Jing, Chen Zhao, Zhang Zhaoyong, Dai Jun, Liu Donglan, Li Yuming, Li Fang, Wang Yanqun, Zhu Airu, Wang Junxiang, Yang Wenhui, Huang Jicheng, Li Xiaobo, Hu Lingfei, Wen Liyan, Zhuo Jianfen, Zhang Yanjun, Chen Dingbin, Li Suxiang, Huang Shuxiang, Shi Yongxia, Zheng Kui, Zhong Nanshan, Zhao Jingxian, Zhou Dongsheng, Zhao Jincun
出版信息
J Exp Med. 2021 Nov 1;218(11). doi: 10.1084/jem.2020218710052021c. Epub 2021 Oct 15.
Abstract
摘要
相似文献
1
Correction: Mapping and role of T cell response in SARS-CoV-2-infected mice.更正：T细胞反应在感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）小鼠中的映射及作用
J Exp Med. 2021 Nov 1;218(11). doi: 10.1084/jem.2020218710052021c. Epub 2021 Oct 15.
2
Understanding the T cell immune response in SARS coronavirus infection.了解严重急性呼吸综合征冠状病毒感染中的T细胞免疫反应。
Emerg Microbes Infect. 2012 Sep;1(9):e23. doi: 10.1038/emi.2012.26. Epub 2012 Sep 5.
3
Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity.解析T细胞对SARS-CoV-2的反应：特异性与偶然性及同源交叉反应性
Front Immunol. 2021 May 28;12:635942. doi: 10.3389/fimmu.2021.635942. eCollection 2021.
4
Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.传染性克隆产生的 SARS-CoV-2 可导致感染 K18-Human ACE2 小鼠发生严重肺部疾病。
mBio. 2021 Apr 20;12(2):e00819-21. doi: 10.1128/mBio.00819-21.
5
Peptides Derived From S and N Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Induce T Cell Responses: A Proof of Concept for T Cell Vaccines.严重急性呼吸综合征冠状病毒2的S蛋白和N蛋白衍生肽诱导T细胞反应：T细胞疫苗的概念验证
Front Microbiol. 2021 Sep 24;12:732450. doi: 10.3389/fmicb.2021.732450. eCollection 2021.
6
A Glimpse into the Diverse Cellular Immunity against SARS-CoV-2.对针对新冠病毒的多样化细胞免疫的一瞥。
Vaccines (Basel). 2021 Jul 27;9(8):827. doi: 10.3390/vaccines9080827.
7
SARS CoV-2 infections in healthcare workers with a pre-existing T-cell response: a prospective cohort study.SARS-CoV-2 感染具有预先存在的 T 细胞反应的医护人员：一项前瞻性队列研究。
Clin Microbiol Infect. 2021 Jun;27(6):916.e1-916.e4. doi: 10.1016/j.cmi.2021.02.020. Epub 2021 Mar 2.
8
SARS-CoV-2 nucleocapsid protein intranasal inoculation induces local and systemic T cell responses in mice.SARS-CoV-2 核衣壳蛋白经鼻腔接种可诱导小鼠产生局部和全身 T 细胞应答。
J Med Virol. 2021 Apr;93(4):1923-1925. doi: 10.1002/jmv.26769. Epub 2021 Jan 11.
9
Case Report: Adequate T and B Cell Responses in a SARS-CoV-2 Infected Patient After Immune Checkpoint Inhibition.病例报告：免疫检查点抑制后 SARS-CoV-2 感染患者的 T 细胞和 B 细胞应答充分。
Front Immunol. 2021 Feb 4;12:627186. doi: 10.3389/fimmu.2021.627186. eCollection 2021.
10
Identification of Unique Peptides for SARS-CoV-2 Diagnostics and Vaccine Development by an Proteomics Approach.采用蛋白质组学方法鉴定 SARS-CoV-2 诊断和疫苗开发的独特肽。
Front Immunol. 2021 Sep 24;12:725240. doi: 10.3389/fimmu.2021.725240. eCollection 2021.
引用本文的文献
1
Highly conserved Betacoronavirus sequences are broadly recognized by human T cells.高度保守的β冠状病毒序列被人类T细胞广泛识别。
Cell. 2025 Jul 30. doi: 10.1016/j.cell.2025.07.015.
2
Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2.对 HCoV-229E 和 HCoV-NL63 敏感的小鼠模型，并可对 SARS-CoV-2 攻击提供交叉保护。
Proc Natl Acad Sci U S A. 2023 Jan 24;120(4):e2202820120. doi: 10.1073/pnas.2202820120. Epub 2023 Jan 18.
3
Non-replicative antibiotic resistance-free DNA vaccine encoding S and N proteins induces full protection in mice against SARS-CoV-2.编码 S 和 N 蛋白的非复制性抗生素耐药性免费 DNA 疫苗可在小鼠中诱导针对 SARS-CoV-2 的完全保护。
Front Immunol. 2022 Nov 9;13:1023255. doi: 10.3389/fimmu.2022.1023255. eCollection 2022.
4
TREM-2 is a sensor and activator of T cell response in SARS-CoV-2 infection.TREM-2是新冠病毒感染中T细胞反应的传感器和激活剂。
Sci Adv. 2021 Dec 10;7(50):eabi6802. doi: 10.1126/sciadv.abi6802. Epub 2021 Dec 8.
Zotero 插件